6931 — Qing Song Health Co Income Statement
0.000.00%
- TWD3.90bn
- TWD4.27bn
- TWD982.56m
- 54
- 12
- 11
- 11
Annual income statement for Qing Song Health Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 240 | 358 | 637 | 869 | 983 |
| Cost of Revenue | |||||
| Gross Profit | 55.1 | 26.8 | 65.6 | 115 | 124 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 210 | 360 | 621 | 815 | 938 |
| Operating Profit | 29.9 | -2.53 | 15.5 | 53.5 | 44.1 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 22.5 | -0.36 | 27.5 | 79.1 | 50.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 16 | 0.215 | 18.5 | 58.8 | 40.7 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 15.8 | -1.97 | 23.3 | 59.4 | 40.6 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 15.8 | -1.97 | 23.3 | 59.4 | 40.6 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.25 | -0.049 | 0.378 | 1 | 0.683 |
| Dividends per Share |